MIAMI, Jan. 12, 2005 (PRIMEZONE) -- Stock Market Alert's watch list includes: Southwestern Medical Solutions Inc (Pink Sheets:SWNM), StemCells, Inc. (Nasdaq:STEM), Apple Computer, Inc. (Nasdaq:AAPL) and Lucent Technologies Inc. (NYSE:LU).
Southwestern Medical Solutions, Inc. (Pink Sheets:SWNM) recently issued a press release that may get investor's attention. The company announced that it has significantly advanced manufacturing specifications for the Protect-A-Pal(tm) needle protection devices. The company's stock closed yesterday at nineteen cents a share.
The press release stated SWNM has discovered the winning combination of manufacturing processes to carry out the completion of this much-awaited device. The technology, for which SWNM has filed patents, combined with a major medical supplier's special polymer technologies/materials, which are approved medically for these purposes, is expected to substantially shorten the time to ultimate commercialization of Protect-A-Pal(tm).
The winning combination of manufacturing processes brings two key achievements to the Company in its efforts to advance Protect-A-Pal to the commercialization stage: 1) The ability to build prototypes much quicker and make necessary changes on the fly, and 2) Use of the latest in medical grade materials which will allow the extrusion of the necessary pieces to fit in a much more precise configuration, removing any of the issues once hindering the release of the product in a timely fashion. Having completed successful prototype testing, minor modifications to the Protect-A-Pal(tm) safety device are being carried out to adapt the technology to several unique applications in the healthcare field.
Given the critical need for an economic, convenient and effective needle-safety device throughout the global healthcare system, the management of Southwestern Medical Solutions, Inc. is extremely optimistic that the Protect-A-Pal(tm) has the potential, when ultimately brought to market, to make rapid and extensive inroads into the billion-dollar needle (and needle-safety!) industry.
Southwestern Medical Has The Solution -- The Company's proprietary Labguard system for on-site collection & diagnostic testing technology represents a revolutionary approach that ensures greater safety and convenience for diagnostic testing administrators at an attractive, market-competitive price. Currently in the final prototype stage, the Labguard system has already attracted expressions of strong interest from several major medical-device distribution companies, both in the U.S. and abroad. Numerous applications of the Labguard system to address specific market needs, such as non-invasive drug screening, HIV testing, etc. are currently in the design, prototype and/or testing stages.
Other stocks of interest yesterday were: StemCells, Inc. (Nasdaq:STEM) up 2.7% on 19.8 million shares traded, Apple Computer, Inc. (Nasdaq:AAPL) down 6.3% on 46.6 million shares traded and Lucent Technologies Inc. (NYSE:LU) down 1.1% on 35.8 million shares traded.
The release is provided by Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company". The company received compensation for services performed for Southwestern Medical Solutions, Inc. (SWNM). The compensation is thirty five thousand dollars from non-affiliated third party, Alex Consulting Inc. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.
The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.
The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.
Investing in the public company that this release is providing service for should be reviewed is speculative and a high-risk and may result in the loss of some or all of any investment.
This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.